glpg.com - GLPG Company profit before taxes, interest and amortization
Galapagos NV relies on licensing payments from partners developing drugs for autoimmune pathologies. The EBITDA trajectory on GURU.Markets reflects the current trend, where the parameter value is 0.00, contrasting with the intense pressure from global players amid biotech oversaturation. Meanwhile, the potential of a new oncology therapy and existing cash reserves are already priced in.
Galapagos (GLPG) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
GLPG - Company Net Income|Forward Earnings Galapagos NV|GLPG - P/E Multiple|Forward P/E Multiple glpg.com|GLPG - PEG Multiple|Enterprise Value to EBITDA Multiple Galapagos|GLPG - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Galapagos|GLPG - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months glpg.com|GLPG - Net earnings per share growth this year|Expected earnings per share trend next year Galapagos NV
Summary company analytics:GLPG (Galapagos Corp)
This indicator measures daily operating profit, allowing for an assessment of cash flow resilience against inflationary shocks and interest rate changes. By analyzing the annual EBITDA, an investor determines the ability of Galapagos NV (GLPG) to monetize developments in oncology and autoimmune diseases, where stable daily income confirms the effectiveness of partnership agreements with pharma behemoths.
Competitors of Galapagos NV (GLPG)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANIP (ANI Pharmaceuticals, Inc.)|Operating profit before depreciation charges MannKind Corp|Amphastar - Operating profit EBITDA|PCRX - Operating profit EBITDA|ARS Pharmaceuticals (SPRY) - Profit before payment of interest, taxes and amortization|TBPH (theravance.com) - Profit before payment of interest, taxes and amortization|AQST (Aquestive Therapeutics, Inc.) - Operating profit EBITDA|Operating profit EBITDA scPharma|Profit before payment of interest, taxes and amortization Tectonic Therapeutic, Inc. (TECX)|TNXP: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Operating profit EBITDA Eupraxia Pharmaceuticals, Inc. EPRX|BioHarvest Sciences Inc. - Operating profit EBITDA|Operating profit before depreciation charges Invizyne Technologies (EXOZ)|oramed.com (ORMP) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Entera Bio (ENTX)|Profit before payment of interest, taxes and amortization MindWalk Holdings|abvcpharma.com (ABVC) - Operating income before deduction of amortization|Operating profit before deduction of amortization CPIX (Cumberland Pharmaceuticals Inc.)|QNTM (Quantum BioPharma Ltd.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization FibroGen Corp FGEN|TELO: Operating profit before amortization|RANI: Operating profit before deduction of amortization|SNYR: Profit before payment of interest, taxes and amortization|RLYB: Operating profit EBITDA|Operating profit before depreciation charges Lexaria Bioscience Corp. LEXX|Profit before payment of interest, taxes and amortization Pulmatrix Corp|Profit before payment of interest, taxes and amortization PTHL|Profit before payment of interest, taxes and amortization Aptorum Group Limited (APM)|LYRA: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA IBO (Impact BioMedical)|Operating profit before depreciation charges TNF Pharmaceuticals Inc.|YCBD - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization PRFX|CYTO: Operating profit EBITDA|lipella.com - Income before deduction of interest, taxes and amortization|OPTN (OptiNose) - Operating profit EBITDA|Operating profit EBITDA Pieris Pharmaceuticals Inc|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|PTPI (Petros Pharma) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Qilian International QLI|SLRN - Operating profit before deduction of amortization|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
